Clinical Trial

Exploratory Study of SHR-A1811 Via Different Administration Routes in Patients

Name: Exploratory Study of SHR-A1811 Via Different Administration Routes in Patients — clinical trial record (NCT07560475)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

An Exploratory Study on the Efficacy and Safety of Different Administration Routes of SHR-A1811 in the Treatment of HER2-Positive Advanced Breast Cancer

Protocol Amendment History 1 change

minor Trial arms changed: 2 -> 3 2026-06-12

Trial Details

NCT Number	NCT07560475
Lead Sponsor	Tianjin Medical University Cancer Institute and Hospital
Conditions	HER2positive, Advanced Breast Cancer, HER2 + Breast Cancer
Enrollment	60 participants
Start Date	2026-06-10
Primary Completion	2028-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-11